Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Nichols Weston

Over the trailing 90 days, Nichols Weston (Director at Crinetics Pharmaceuticals, Inc.) bought $206K of stock across 2 companies, per 3 SEC Form 4 transactions.

Role: Director
Companies: CRNX PASG
Window: Trailing 90 days · 3 transactions · CIK 1746376
Net activity: +$206K ($206K bought · $0 sold)
Source: Official filings on sec.gov ↗

By Company (Trailing 90 Days)

Symbol	Company	Txns	Bought	Sold	Net
PASG	Passage BIO, Inc.	1	$206K	—	$206K
CRNX	Crinetics Pharmaceuticals, Inc.	2	—	—	$0

Transactions (3)

Date	Symbol	Type	Shares	Value	Description
2026-06-25	PASG	Buy	50.1K	$206K	Open market or private purchase
2026-06-18	CRNX	Buy	5.9K	$0	Grant, award or other acquisition
2026-06-18	CRNX	Buy	9.7K	$0	Grant, award or other acquisition

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Nichols's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free